Evidence depth: moderate · High public-data fit

Anesthesia / Pain

A specialty deeply bifurcated between the OR (general anesthesia, shift-based, high income but zero ownership) and the clinic (interventional pain, ASC ownership, highly lucrative but facing persistent reimbursement cuts).

Where to start

Best-fit Anesthesia / Pain paths

Directional, modeled. Your priorities decide. Build a report to make it yours.

Data Highlights

Specialty Insights

Public data · NPPES68,414 clinicians in the NPI registry roster. Registration, not verified active practiceTop states: CA, NY, TXAggregate workforce/geography, not income.
Competitiveness context: competitive - NRMP 2024
2,200 positions offeredmoderate-high applicants-per-position tierNRMP 2024 Main Residency Match published specialty tables
Modeled Paths
7
Top Modeled Ceiling
$900k - $1.5M+
Best Lifestyle Path
Interventional Pain
Highest Equity Upside
Interventional Pain

Public data · CMS Medicare Part B

What this specialty actually bills Medicare

Reviewed. Medicare procedure mix mapped
Aggregate allowed amount
$1.5B
Medicare Part B, not income
Providers in panel
69,020
NPPES individual NPIs
NPI → Medicare join
53%
billed Medicare in the year
Open Payments physicians
21,303
transfers of value, not income

Medicare allowed-$ by subspecialty sector (public CMS data)

General Anesthesia
$483M
Interventional Pain
$106M

Top procedures by Medicare allowed-$ (public CMS data)

  • 00142 · Anesthesia for lens surgery$69M
  • 00731 · Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope$57M
  • 00811 · Anesthesia for other procedure on large bowel using an endoscope$48M
  • 64635 · Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint$44M
  • 01402 · Anesthesia for procedure for total knee joint replacement$37M

Source: CMS Medicare Physician & Other Practitioners (public). This is not W-2 salary, total collections, or take-home income. Aggregate allowed amounts are a partial, biased slice of one payer; sector labels are keyword-inferred from public procedure descriptions and are directional, pending physician review.

Paths

Path families to test

Path Landscape

Compare all 7 paths

Premium tool

Unlock 10-dimension comparison matrix

See exactly how every path stacks up across lifestyle, sleep, ownership, and income.

Unlock premium

Path battle card

Compare head-to-head

VS

Anesthesia / Pain

General Anesthesia

Really about: high-income, shift-based OR work with minimal business upside

validated confidence

Anesthesia / Pain

Interventional Pain

Really about: high-volume outpatient injections and nerve blocks with massive ASC upside

validated confidence
1. Income ceilingedge → Interventional Pain
Mixed

Solid and highly reliable, but strictly capped by physical hours worked.

The reality · The signal · The catch · The verdict

The reality: You are essentially paid for your physical time spent in the operating room or supervising.

The signal: Supervising CRNAs in a 1:4 ratio increases your leverage, but the ultimate ceiling remains hard-capped.

The catch: Working locum tenens can artificially spike your income, but requires sacrificing stability and benefits.

The verdict: Provides a phenomenal living, but it is structurally not a top-tier wealth-builder lane due to lack of equity.

Favorable

A very strong ceiling driven by ancillary services and massive procedure volume.

The reality · The signal · The catch · The verdict

The reality: Routine procedures like epidurals, facet blocks, and radiofrequency ablations are highly efficient.

The signal: ASC ownership and in-house toxicology labs act as massive multipliers on your base professional income.

The catch: While CMS reimbursement cuts have hurt the field, the ceiling remains incredibly high for efficient operators.

The verdict: Provides an excellent, top-tier ceiling for a purely outpatient, non-surgical specialty.

2. Lifestyle controledge → Interventional Pain
Favorable

Shift work offers distinct, protected time off, but absolutely zero daily autonomy.

The reality · The signal · The catch · The verdict

The reality: When you are on the clock, you are entirely tethered to the OR table and the surgeon's pace.

The signal: The massive benefit is that you never take your work home; there is zero clinic and zero inbox to manage.

The catch: Requires accepting that you will miss weekends and holidays regularly based on the shift schedule.

The verdict: Offers excellent macro-predictability, but low micro-control over the work itself.

Favorable

Exceptional control; one of the best schedules in all of medicine.

The reality · The signal · The catch · The verdict

The reality: The practice is 100% outpatient, elective, and scheduled weeks in advance.

The signal: You have total control over the pace of your clinic and your injection blocks.

The catch: There are absolutely no hospital rounds and no emergent surgeries to disrupt your day.

The verdict: The most controllable subspecialty within the anesthesia umbrella.

Premium tool

Unlock full battle card

See exactly who wins on sleep, call burden, equity upside, and 5 more vectors.

Unlock premium
11. What people regret
  • Missing out on the ASC ownership boom by refusing to hustle for equity.
  • Feeling like a highly paid technician who is easily replaced by private equity staffing models.
  • The emotional exhaustion of dealing with drug-seeking patients and chronic, unsolvable pain.
  • The relentless, soul-crushing battles with insurance companies over prior authorizations for simple injections.
12. Best-fit archetypes
Flexible High-Earner
Owner-Operator Physician, Procedure-Heavy Wealth Builder
13. Poor-fit archetypes
Owner-Operator Physician, Entrepreneurial Physician
Acute-Care Identity Seeker
14. Questions to ask mentors / fellowships / jobs
  • Is this a 'supervision' model (overseeing 4 CRNAs) or 'doing your own cases'?
  • Are there mandatory overnight calls, or is it a strict shift model?
  • If it's a private group, has it been bought by a national management company (Envision, TeamHealth, etc.)?
  • What is the buy-in structure for the ASC and the urine toxicology lab?
  • What is the group's strict policy on chronic opioid prescribing versus interventional procedures?
  • Are there private equity restrictions or onerous non-competes in this specific market?

Evidence & reveals

Clinician assumptionmoderate

General anesthesia is a direct trade of time for money.

Why · signal · limit · impact

Why: Without ownership, you cannot decouple your income from your physical presence in the OR.

Signal: Industry data shows massive consolidation by PE, turning partners into employees.

Caveat: The market is red-hot now, but the long-term ceiling is fixed.

Impact: A very honest, highly paid path.

Clinician assumptionmoderate

Interventional pain wealth relies heavily on ASC ownership and device implants (SCS).

Why · signal · limit · impact

Why: Without the facility fee, doing 20 epidurals a day is exhausting and underpaid.

Signal: Industry data shows toxicology and ASCs are the main profit engines.

Caveat: Do not take a private job without a clear path to ASC ownership.

Impact: Push for ownership.

Scores are relative, directional signals, not dollars and never a salary claim. Each carries its own why, supporting signal, limitation, and decision impact, and the confidence badge shows how validated each path is.

Field notes

  • General anesthesia is heavily corporatized (PE roll-ups, CRNA supervision models), making true partnership rare. Pain medicine remains one of the most viable independent ASC plays.

Common regret patterns

  • Choosing pain medicine purely for the money but hating the chronic pain patient population.
  • Staying a 'W2 worker bee' in a mega-anesthesia group with absolutely no path to equity.

Questions to ask

  • Where did recent graduates land, and at what real compensation model?
  • What's the realistic path to ownership or production upside?

Run your personalized report

Premium turns your target life into a required-income number, then tests it against these paths for salary-only gap, ownership upside, call burden, and geography. Evidence depth and confidence stay visible inside every report.